Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge
|ClinicalTrials.gov Identifier: NCT00604370|
Recruitment Status : Completed
First Posted : January 30, 2008
Last Update Posted : February 10, 2012
|Condition or disease|
It appears likely that many patients will remain at risk for VTE at the time of hospital discharge. These risks will go unrecognized, and discharge prophylaxis orders will not be prescribed.
To test this hypothesis, we will perform a retrospective review of approximately 2,500 patients at Brigham and Women's Hospital at risk for VTE at the time of hospital discharge to determine what proportion received VTE prophylaxis. We will correlate the implementation of discharge VTE prophylaxis with the occurrence of symptomatic DVT and pulmonary embolism within 90 days of hospital discharge.
We will also conduct a substudy of this patient population to determine adherence to VTE prophylaxis among hospitalized patients.
|Study Type :||Observational|
|Actual Enrollment :||2500 participants|
|Observational Model:||Case Control|
|Official Title:||VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge|
|Study Start Date :||February 2008|
|Actual Primary Completion Date :||February 2010|
|Actual Study Completion Date :||December 2011|
Acutely ill medical and surgical patients who were hospitalized at BWH, and at-risk for VTE, but were not treated with prophylaxis at hospital discharge.
Acutely ill medical and surgical patients who were at risk for VTE at time of hospital discharge and prescribed a prophylaxis strategy.
- Symptomatic PE/DVT within 90 days of hospital discharge. [ Time Frame: 90 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00604370
|Principal Investigator:||Samuel Z Goldhaber, MD||Brigham and Women's Hospital|